Hepasonica Arabia, based in the United Arab Emirates a global pharmaceutical group focused on advanced therapies in anticoagulation, glycosaminoglycans, and peptide-based medicines.

At Hepasonica, we are committed to transforming patient care through ethical innovation, precision science, and robust quality systems. Leveraging advanced manufacturing, strong R&D capabilities, and regulatory foresight, we respond to the evolving needs of cardiovascular, hematologic, and surgical care across the MENA and GCC regions.

With guidance from internationally renowned scientific advisors and a solid foundation in GMP and global compliance, Hepasonica Arabia ensures that every product meets the highest international standards — while honoring the clinical and cultural values of our region.